Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hans Edgar Bishop Insider Profile
11 Followers
Hans Edgar Bishop, CEO & President, Director at Juno Therapeutics, holds 5.79M shares in Sana Biotechnology (Ticker: SANA), holds 24.98K shares in Agilent (Ticker: A), holds 4.69M shares in Lyell Immunopharma (Ticker: LYEL).
Hans Edgar Bishop Juno Therapeutics (JUNO)CEO & President, Director
Juno Therapeutics (JUNO)
CEO & President, Director
Not Ranked
Hans Edgar Bishop has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Hans Edgar Bishop holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Hans Edgar Bishop
Hans Edgar Bishop's Trading History
Juno Therapeutics
Mar 07, 2018
―
Uninformative Sell
201.21M
$0.00
Agilent
Mar 19, 2024
Director
Uninformative Buy
358.08K
$3.45M
Celgene
Nov 22, 2019
―
Uninformative Sell
―
$0.00
Lyell Immunopharma
Sep 09, 2022
Director
Uninformative Buy
14.54K
$4.31M
Sana Biotechnology
Oct 09, 2024
Director
Uninformative Buy
―
$14.77M
Dendreon Corp
Aug 02, 2011
―
Uninformative Sell
86.26K
―
Avanir Pharmaceuticals
Feb 14, 2014
―
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see Hans Edgar Bishop's performance on stock
You May Also Like
Hans Edgar Bishop insider profile FAQ
What is the percentage of profitable transactions made by Hans Edgar Bishop?
The percentage of profitable transactions made by Hans Edgar Bishop is ―.
What is the average return per transaction made by Hans Edgar Bishop?
The average return per transaction made by Hans Edgar Bishop is ―.
What stocks does Hans Edgar Bishop hold?
Hans Edgar Bishop holds: JUNO, A, CELG, LYEL, SANA, DNDNQ, AVNR stocks.
What was Hans Edgar Bishop’s latest transaction?
Hans Edgar Bishop latest transaction was an Uninformative Buy of ―.
What was Hans Edgar Bishop's most profitable transaction?
Hans Edgar Bishop’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Hans Edgar Bishop's role in Juno Therapeutics?
Hans Edgar Bishop's role in Juno Therapeutics is CEO & President, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.